The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics, treatment, and outcomes of cutaneous mantle cell lymphoma: A decade-long study at MD Anderson Cancer Center.
 
Charles Gaulin
Honoraria - ADC Therapeutics; DeciBio; Sanofi
 
Jared R. Zhang
No Relationships to Disclose
 
Susan Y. Wu
No Relationships to Disclose
 
Preetesh Jain
No Relationships to Disclose
 
Chi Ok
No Relationships to Disclose
 
Fangfang Yan
No Relationships to Disclose
 
Wendy Chen
No Relationships to Disclose
 
Onyeka Oriabure
No Relationships to Disclose
 
Bouthaina Shbib Dabaja
No Relationships to Disclose
 
Jillian Rebecca Gunther
Honoraria - Osler Institute
 
Penny Fang
No Relationships to Disclose
 
Chelsea Camille Pinnix
Employment - MD Anderson Cancer Center
Stock and Other Ownership Interests - Neumentum (I)
Honoraria - International Journal of Radiation Oncology Biology Physics
Consulting or Advisory Role - American Society of Therapeutic Radiation Oncology
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Michael Wang
Honoraria - Abbvie; Acerta Pharma; AstraZeneca; BeiGene; Bioinvent; Bristol Myers Squibb Foundation; CAHON; Catamount Medical Education; Dava Oncology; Genmab; Janssen Research & Development; Kite, a Gilead company; Merck; MSC National Research Institute of Oncology; NIH; Nurix; OncLive/MJH Life Sciences; Pharmacyclics/Janssen; Physicans' Education Resource; Research to Practice; Scripps Health; South African Clinical Hematology Society; Studio ER Congressi
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; Amphista Therapeutics; AstraZeneca; BeiGene; Bioinvent; Deciphera; Genentech; Innocare; Janssen Research & Development; Kite, a Gilead company; Lilly; Merck; Miltenyi Biomedicine; Oncternal Therapeutics; Parexel; Pepromene; Pepromene; Pharmacyclics/Janssen; VelosBio
Research Funding - Acerta Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Bioinvent (Inst); Celgene (Inst); Genentech (Inst); Genmab (Inst); Innocare (Inst); Janssen Research & Development (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Loxo (Inst); Molecular Templates (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst); VelosBio (Inst); Vincerx Pharma (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Kite, a Gilead company; Physicans' Education Resource